Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Skye Bioscience Inc (SKYE)

Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,789
  • Shares Outstanding, K 32,057
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,570 K
  • EBIT $ -54 M
  • EBITDA $ -53 M
  • 60-Month Beta 2.68
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.05

Options Overview Details

View History
  • Implied Volatility 479.03% (+34.97%)
  • Historical Volatility 89.08%
  • IV Percentile 86%
  • IV Rank 55.63%
  • IV High 783.06% on 12/20/24
  • IV Low 97.86% on 04/04/25
  • Expected Move (DTE 14) 1.1475 (94.83%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 93
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 8,456
  • Open Int (30-Day) 9,278
  • Expected Range 0.0625 to 2.3575

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 4
  • High Estimate -0.20
  • Low Estimate -0.36
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -20.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +10.00%
on 12/02/25
1.5997 -24.36%
on 11/06/25
-0.2100 (-14.79%)
since 11/04/25
3-Month
1.1000 +10.00%
on 12/02/25
4.9902 -75.75%
on 10/03/25
-2.5400 (-67.73%)
since 09/04/25
52-Week
1.1000 +10.00%
on 12/02/25
5.7500 -78.96%
on 06/27/25
-2.6400 (-68.57%)
since 12/04/24

Most Recent Stories

More News
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options

SKYE : 1.2100 (-0.82%)
Shareholders of Skye Bioscience, Inc. Should Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE

NEW YORK , Dec. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE).

SKYE : 1.2100 (-0.82%)
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE

LOS ANGELES , Dec. 4, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against  Skye Bioscience, Inc. ("Skye " or "the Company") (NASDAQ: SKYE ) for violations...

SKYE : 1.2100 (-0.82%)
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Dec. 4, 2025 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience,...

SKYE : 1.2100 (-0.82%)
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing

PHILADELPHIA , Dec. 3, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC  announces that a class action lawsuit has been filed against Skye Bioscience, Inc. (NASDAQ:...

SKYE : 1.2100 (-0.82%)
SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit

SAN DIEGO , Dec. 2, 2025 /PRNewswire/ -- Company : Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled...

SKYE : 1.2100 (-0.82%)
Investors in Skye Bioscience, Inc. Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE

NEW YORK , Dec. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Skye Bioscience, Inc. ("Skye Bioscience, Inc." or the "Company") (NASDAQ: SKYE) of a class action securities...

SKYE : 1.2100 (-0.82%)
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

NEW YORK , Dec. 1, 2025 /PRNewswire/ --

SKYE : 1.2100 (-0.82%)
Skye Bioscience, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - SKYE

NEW YORK , Dec. 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  Skye Bioscience, Inc. (NASDAQ: SKYE).

SKYE : 1.2100 (-0.82%)
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE

LOS ANGELES , Dec. 1, 2025 /PRNewswire/ --  The DJS Law Group  reminds investors of a class action lawsuit against  Skye Bioscience, Inc. ("Skye " or "the Company") (NASDAQ: SKYE ) for...

SKYE : 1.2100 (-0.82%)

Business Summary

Skye Bioscience Inc. is a biopharmaceutical company. It is focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need. Skye Bioscience Inc., formerly known as Emerald Bioscience Inc., is based in San Diego, Calif.

See More

Key Turning Points

3rd Resistance Point 1.3000
2nd Resistance Point 1.2700
1st Resistance Point 1.2400
Last Price 1.2100
1st Support Level 1.1800
2nd Support Level 1.1500
3rd Support Level 1.1200

See More

52-Week High 5.7500
Fibonacci 61.8% 3.9737
Fibonacci 50% 3.4250
Fibonacci 38.2% 2.8763
Last Price 1.2100
52-Week Low 1.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar